Building Your

Custom Intelligence Blueprint

600+ Arancans and 5 complementary practices enable you to Decide Fearlessly.

Explore

In the spotlight - Blog

The Bayer Monsanto Deal is Set to Transform the Agri-business Industry

Under pressure to shield its turf from increasing market consolidation, Bayer may have finally found the firm footing it needs.

Read More

In the spotlight - Article

Is the ECB Fuelling an Asset Bubble in the European Corporate Debt Market?

ECB maintains status quo; continues to blow a growing asset bubble.

Read More

In the spotlight - Article

How Risk Return Relative Value Approach Helps Create Higher Alpha for Global Credit Portfolios

Security selection for a Fixed Income Investment portfolio is a critical task in the entire portfolio management process. In contrast to the conventional top-down approach, the Risk Return Relative Value approach offers an alternate investment screening mechanism that helps generate higher returns for investors.

Read More

In the spotlight - Blog

Supplier Diversity — Are You Benchmarking Correctly?

An inability to determine the right parameters for success and not knowing the best performance benchmarks can easily derail even the most robust supplier diversity program. Benchmarking is your first step. Know what's the best way forward.

Read More

In the spotlight - Blog

Can Banking Shape Up in a Digital World?

While we’re still trying to figure out the “Internet of Things” and how it could possibly change anything, you’ve probably missed a silent revolution that’s already well underway.

Read More

In the spotlight - Special Report

Cardiac Nuclear Imaging and Radiotracers

Recent novel radiopharmaceuticals agents developed to target specific subcellular process are capable of significantly improving diagnostic accuracy and prognostic evaluation.

The global nuclear medicine diagnostic (PET and SPECT) market is slated to cross $ 16 billion by 2019, primarily driven by more accurate diagnostic utilities in identifying the functional and perfusion status of targeted tissues.

Read More